Back to Search
Start Over
Irinotecan, mitomycin, and raltitrexed (CMT) combination chemotherapy in heavily pretreated colorectal cancer (CRC) patients
- Source :
- Journal of Clinical Oncology. 29:e14104-e14104
- Publication Year :
- 2011
- Publisher :
- American Society of Clinical Oncology (ASCO), 2011.
-
Abstract
- e14104 Background: Therapeutic options for patients (pts) with advanced colorectal cancer (CRC) that have progressed to irinotecan- and oxaliplatin-based combination chemotherapy are few. Raltitrex...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
business.industry
Colorectal cancer
Combination chemotherapy
medicine.disease
digestive system diseases
Oxaliplatin
Advanced colorectal cancer
Irinotecan
stomatognathic diseases
health services administration
Irinotecan/Mitomycin
Internal medicine
Medicine
business
therapeutics
neoplasms
Raltitrexed
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 29
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........2f0531665fdd5874019a58881c9a6157
- Full Text :
- https://doi.org/10.1200/jco.2011.29.15_suppl.e14104